These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 3080285)
1. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Lanza FL Dig Dis Sci; 1986 Feb; 31(2 Suppl):131S-136S. PubMed ID: 3080285 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266 [TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects]. Naves J; Santoyo R; Morales I Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571 [TBL] [Abstract][Full Text] [Related]
4. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Lanza F; Peace K; Gustitus L; Rack MF; Dickson B Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic efficacy of misoprostol in peptic ulcer disease. Watkinson G; Hopkins A; Akbar FA Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682 [TBL] [Abstract][Full Text] [Related]
6. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study. Silverstein FE; Kimmey MB; Saunders DR; Levine DS Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286 [TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187 [TBL] [Abstract][Full Text] [Related]
8. Misoprostol versus cimetidine in tolmetin-induced mucosal injury. Wallin BA; Frank WO; Young MD Gastroenterology; 1989 May; 96(5 Pt 1):1374-6. PubMed ID: 2495235 [No Abstract] [Full Text] [Related]
9. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin-stimulated recovery of the human duodenal epithelium: effects of misoprostol on ethanol damage. Foschi D; Marazzi M; Toti GL; Radaelli E; Ferrante F; Vaiani G; Galeone M; Trabucchi E Am J Gastroenterol; 1990 Nov; 85(11):1498-502. PubMed ID: 2122722 [TBL] [Abstract][Full Text] [Related]
12. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Agrawal NM; Godiwala T; Arimura A; Dajani EZ Gastrointest Endosc; 1986 Apr; 32(2):67-70. PubMed ID: 3086177 [TBL] [Abstract][Full Text] [Related]
13. Protection by misoprostol against naproxen-induced gastric mucosal damage. Aadland E; Fausa O; Vatn M; Cohen H; Quinlan D Am J Med; 1987 Jul; 83(1A):37-40. PubMed ID: 3113244 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619 [TBL] [Abstract][Full Text] [Related]
15. Protection of the gastroduodenal mucosa from the effects of diclofenac sodium: role of highly selective vagotomy and misoprostol. Giannoukas AD; Baltoyiannis G; Milonakis M; Nastos D; Papagikos L; Kappas AM; Fatouros M; Papadimitriou C; Cassioumis D World J Surg; 1996 May; 20(4):501-5 discussion 505-6. PubMed ID: 8662142 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic assessment of the effects of dipyrone (metamizol) in comparison to paracetamol and placebo on the gastric and duodenal mucosa of healthy adult volunteers. Bianchi Porro G; Ardizzone S; Petrillo M; Caruso I; Montrone F Digestion; 1996; 57(3):186-90. PubMed ID: 8739093 [TBL] [Abstract][Full Text] [Related]
17. Overview of the mucosal protective effects of misoprostol in man. Dajani EZ Prostaglandins; 1987; 33 Suppl():117-29. PubMed ID: 3122272 [TBL] [Abstract][Full Text] [Related]
18. Effects of alendronate on gastric and duodenal mucosa. Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122 [TBL] [Abstract][Full Text] [Related]
19. Protective effects against alcohol insult: does somatostatin play any role? Agrawal NM; Godiwala T; Arimura A; Groot K; Dajani E Postgrad Med J; 1988; 64 Suppl 1():15-20. PubMed ID: 2901743 [TBL] [Abstract][Full Text] [Related]
20. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study. Silverstein FE; Kimmey MB; Saunders DR; Surawicz CM; Willson RA; Silverman BA Am J Med; 1987 Jul; 83(1A):32-6. PubMed ID: 3113243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]